Impeto Medical

Impeto Medical, established in June 2005, is a medical device company focused on developing non-invasive screening tests for metabolic disorders and their complications. The company was acquired by Withings, a leader in connected health technology, in November 2021, a move designed to integrate Impeto's technology into a new generation of at-home health monitoring devices. Prior to its acquisition, Impeto Medical had raised $14.3 million in funding.

The firm's core business revolves around the manufacturing and sale of medical devices that enable early and rapid detection of peripheral neuropathies, which are particularly prevalent in conditions like diabetes. The primary clients are healthcare professionals in pharmacies, medical offices, and hospitals. Its business model is based on the sale of these devices and likely involves recurring revenue from the consumables (electrodes) required for the tests. The company operates globally with a significant presence in the United States and China.

Impeto Medical's flagship product is the SUDOSCAN, an FDA-cleared and CE-marked device that provides a quantitative assessment of sudomotor (sweat gland) function. The test takes less than three minutes and is non-invasive, requiring the patient to simply place their hands and feet on stainless steel electrode plates. A low-voltage current is applied, and the device measures the electrochemical skin conductance by analyzing the flow of chloride ions from sweat glands. This measurement serves as a biomarker for the health of small C-fiber nerves, which are often the first to be affected by neuropathy. The results help physicians to detect conditions such as diabetic neuropathy, chemotherapy-induced polyneuropathy, and other autonomic dysfunctions at an early stage, allowing for timely intervention and patient management. The technology's efficacy is supported by over 150 published articles and 15 patents.

Keywords: SUDOSCAN, sudomotor function test, peripheral neuropathy detection, small fiber neuropathy, diabetic neuropathy screening, electrochemical skin conductance, non-invasive diagnostics, medical devices, autonomic dysfunction, Withings, sweat gland function, neuropathy monitoring, early disease detection, chronic condition management, CE mark, FDA cleared, chemotherapy-induced polyneuropathy, prediabetes, metabolic disorders, diagnostic equipment